Submit Deal

GERON CORPORATION

HQ - Menlo Park

Summary

Geron Corporation a commercial-stage biopharmaceutical company specializing in developing therapeutic products for cancer that inhibit telomerase.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 291 M

Avg. Deal Size£ 291 M

Market Context

Senior Management

Michelle Robertson
Executive Vice President and CFO
Aron Feingold
Vice President, Investor Relations and Corporate Communications
Kristen Kelleher
Associate Director, Investor Relations and Corporate Communications

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Michelle Robertson
Executive Vice President and CFO
Aron Feingold
Vice President, Investor Relations and Corporate Communications
Kristen Kelleher
Associate Director, Investor Relations and Corporate Communications